Lipid metabolism reprogramming in cardiac fibrosis

LC Lin, ZY Liu, JJ Yang, JY Zhao, H Tao - Trends in Endocrinology & …, 2024 - cell.com
Cardiac fibrosis is a critical pathophysiological process that occurs with diverse types of
cardiac injury. Lipids are the most important bioenergy substrates for maintaining optimal …

Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis

K Abe, M Ikeda, T Ide, T Tadokoro, HD Miyamoto… - Science …, 2022 - science.org
Clinical use of doxorubicin (DOX) is limited because of its cardiotoxicity, referred to as DOX-
induced cardiomyopathy (DIC). Mitochondria-dependent ferroptosis, which is triggered by …

The mechanism of ferroptosis and its related diseases

S Feng, D Tang, Y Wang, X Li, H Bao, C Tang… - Molecular …, 2023 - Springer
Ferroptosis, a regulated form of cellular death characterized by the iron-mediated
accumulation of lipid peroxides, provides a novel avenue for delving into the intersection of …

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy

H Sun, D Chen, W Xin, L Ren, Q Li… - Frontiers in pharmacology, 2023 - frontiersin.org
Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized
by heart muscle damage, resulting in myocardium disorders, diminished cardiac function …

Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and …

VV Ryabov, LN Maslov, EV Vyshlov… - International Journal of …, 2024 - mdpi.com
The hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is
about 6% and has not decreased in recent years. The leading cause of death of these …

Cardiac autoantibodies against cardiac troponin I in post-myocardial infarction heart failure: evaluation in a novel murine model and applications in therapeutics

S Furusawa, M Ikeda, T Ide, T Kanamura… - Circulation: Heart …, 2023 - Am Heart Assoc
BACKGROUND: Cardiac autoantibodies (cAAbs) are involved in the progression of adverse
cardiac remodeling in heart failure (HF). However, our understanding of cAAbs in HF is …

Ferroptosis: a new strategy for cardiovascular disease

Y Wang, J Wu - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Cardiovascular disease (CVD) is currently one of the prevalent causes of human death. Iron
is one of the essential trace elements in the human body and a vital component of living …

Immunomodulatory cell therapy using αGalCer-pulsed dendritic cells ameliorates heart failure in a murine dilated cardiomyopathy model

M Ikeda, T Ide, S Matsushima, S Ikeda… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: Dilated cardiomyopathy (DCM) is a life-threatening disease, resulting in
refractory heart failure. An immune disorder underlies the pathophysiology associated with …

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases

Y Zou, H Shi, N Liu, H Wang, X Song… - Frontiers in …, 2023 - frontiersin.org
Heat shock protein 27 (HSP27) is a small chaperone protein that is overexpressed in a
variety of cellular stress states. It is involved in regulating proteostasis and protecting cells …

The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity

J Zhao, N Zhang, X Ma, M Li, H Feng - Cell Death Discovery, 2023 - nature.com
In conjunction with previous studies, we have noted that ferroptosis, as an emerging mode of
regulated cell death (RCD), is intimately related to anthracycline pharmacotherapy. Not only …